Stocks
Neurocrine Biosciences (NBIX) P/E US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | 89.9 | 74.1 | 51.6 | 40.2 | 29.5 | 22.5 | ||
| Changes by years, y/y, % | +310% | -18% | -30% | -22% | -27% | +6.1% | |||
Neurocrine Biosciences. P/E
Neurocrine Biosciences. P/E, changes, %
Neurocrine Biosciences (NBIX) P/E US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/E | ? | 36.1 | 35.7 | 32.6 | 29.5 | 19.8 | 22.5 | |
| Changes by years, y/y, % | -3% | -13% | +8% | -26% | -45% | |||
| Changes by quarters, q/q, % | -10% | -1% | -9% | -10% | -33% | |||
